- Home
- RVPHW vs IVAC Comparison
RVPHW vs IVAC Comparison
Compare RVPHW & IVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- IVAC
- Stock Information
- Founded
- RVPHW 2018
- IVAC 1990
- Country
- RVPHW United States
- IVAC United States
- Employees
- RVPHW N/A
- IVAC N/A
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- IVAC Industrial Machinery/Components
- Sector
- RVPHW Health Care
- IVAC Technology
- Exchange
- RVPHW Nasdaq
- IVAC Nasdaq
- Market Cap
- RVPHW N/A
- IVAC N/A
- IPO Year
- RVPHW N/A
- IVAC 1995
- Fundamental
- Price
- RVPHW $0.06
- IVAC $4.02
- Analyst Decision
- RVPHW
- IVAC Hold
- Analyst Count
- RVPHW 0
- IVAC 1
- Target Price
- RVPHW N/A
- IVAC N/A
- AVG Volume (30 Days)
- RVPHW 22.4K
- IVAC 867.5K
- Earning Date
- RVPHW 03-14-2025
- IVAC 04-24-2025
- Dividend Yield
- RVPHW N/A
- IVAC 1.24%
- EPS Growth
- RVPHW N/A
- IVAC N/A
- EPS
- RVPHW N/A
- IVAC N/A
- Revenue
- RVPHW N/A
- IVAC $63,978,000.00
- Revenue This Year
- RVPHW N/A
- IVAC N/A
- Revenue Next Year
- RVPHW N/A
- IVAC N/A
- P/E Ratio
- RVPHW N/A
- IVAC N/A
- Revenue Growth
- RVPHW N/A
- IVAC 21.48
- 52 Week Low
- RVPHW $0.13
- IVAC $2.46
- 52 Week High
- RVPHW $0.15
- IVAC $4.42
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- IVAC 66.83
- Support Level
- RVPHW N/A
- IVAC $4.03
- Resistance Level
- RVPHW N/A
- IVAC $4.04
- Average True Range (ATR)
- RVPHW 0.00
- IVAC 0.02
- MACD
- RVPHW 0.00
- IVAC -0.02
- Stochastic Oscillator
- RVPHW 0.00
- IVAC 50.00
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.